Filing Details
- Accession Number:
- 0000899243-22-007921
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-25 17:08:13
- Reporting Period:
- 2022-02-23
- Accepted Time:
- 2022-02-25 17:08:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1538927 | Forma Therapeutics Holdings Inc. | FMTX | Biological Products, (No Disgnostic Substances) (2836) | 371657129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1814771 | F. Patrick Kelly | C/O Forma Therapeutics Holdings, Inc. 300 North Beacon Street, Suite 501 Watertown MA 02472 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-23 | 5,245 | $9.78 | 64,884 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The Form 4 filed by the reporting person on March 2, 2021 inadvertently understated the number of shares of Common Stock directly held by the reporting person by 42,959 shares.
Billionaire Hedge Funds
